FredericJosephKayeMD
Oncology • Gainesville, FLHead & Neck Cancer, Hematologic Oncology, Thoracic Cancer
Professor, Medicine, University of Florida College of Medicine
Dr. Kaye is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1535 Gale Lemerand Dr
Gainesville, FL 32610Phone+1 352-265-0725Fax+1 352-627-4150- Is this information wrong?
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1984 - 1987
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1982 - 1984- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1979 - 1982
University of Maryland School of MedicineClass of 1979
Certifications & Licensure
FL State Medical License 2009 - 2025
MD State Medical License 1985 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 2001
Clinical Trials
- Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC) Start of enrollment: 2011 Dec 01
- Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer Start of enrollment: 2013 Feb 01
- Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection Start of enrollment: 2020 Oct 26
Publications & Presentations
PubMed
- PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer.Sajid Khan, Lin Cao, Janet Wiegand, Peiyi Zhang, Maria Zajac-Kaye, Guangrong Zheng, Daohong Zhou, Frederic J Kaye> ;Cells. 2024 Mar 17
- PROTAC-mediated dual degradation of BCL-xL and BCL-2 is a highly effective therapeutic strategy in small-cell lung cancer.Sajid Khan, Lin Cao, Janet Wiegand, Peiyi Zhang, Maria Zajac-Kaye, Frederic J Kaye, Guangrong Zheng, Daohong Zhou> ;Biorxiv. 2024 Mar 1
- Disparities Contributing to Late-Stage Diagnosis of Lung, Colorectal, Breast, and Cervical Cancers: Rural and Urban Poverty in Florida.Jaclyn M Hall, Rahma S Mkuu, Hee Deok Cho, Jennifer N Woodard, Frederic J Kaye, Jiang Bian, Elizabeth A Shenkman, Yi Guo> ;Cancers. 2023 Oct 31
- Join now to see all
Press Mentions
Advanced Screening Shows Promise in Detecting Lung CancerOctober 22nd, 2015
Grant Support
- Mechanisms Of Oncogene Action In TumorigenesisNational Cancer Institute2010
- Mechanisms Of Oncogene Action In TumorigenesisDivision Of Clinical Sciences - Nci2009
- Mechanisms Of Oncogene Action In TumorigenesisNational Cancer Institute2007–2008
- Mechanisms Of Oncogene Action In TumorigenesisDivision Of Clinical Sciences - Nci1996–2006
Professional Memberships
- Member
Hospital Affiliations
UF Health Shands HospitalGainesville, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
